Dr. Scott Wong contributes to Wong's Bio Tech Stock Report, an online publication dedicated to independent biotechnology equity research. Wong is a virologist at the OHSU Gene Therapy and Cancer Vaccine Institute and a Professor at Oregon Health Sciences University. He received his Ph.D from Stanford University School of Medicine in Cancer Biology and did his post-doctoral work in virology at Dana Farber Cancer Institute, a well known affiliate of Harvard University. He has published many papers regarding his scientific research and has formed collaborations with major universities and pharmaceuticals companies.